Showing 1 - 4 results of 4 for search 'C. Fernandez De Larrea', query time: 0.02s Refine Results
  1. 1
    Study of the antibody response against Mycobacterium tuberculosis antigens in Warao Amerindian children in Venezuela

    Study of the antibody response against Mycobacterium tuberculosis antigens in Warao Amerindian children in Venezuela by Z Araujo, JH de Waard, C Fernández de Larrea, D López, C Fandiño, A Maldonado, E Hernández, Y Ocaña, R Ortega, M Singh, Tom HM Ottenhoff, SM Arend, J Convit

    Published 2004-08-01
    Get full text
    Article
  2. 2
    P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY

    P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY by I. Ortiz De Landazuri, A. Oliver-Caldés, M. Español-Rego, M. T. Contreras, A. Zabaleta, C. Agulló, N. Puig, V. Cabañas, V. González-Calle, R. Jiménez, S. Inogés, P. Rodríguez-Otero, B. Martin-Antonio, J. L. Reguera, A. López-Diaz de Cerio, D. Benítez-Ribas, L. G. Rodríguez-Lobato, E. A. González, L. Rosiñol, J. Yagüe, J. M. Moraleda, Á. Urbano-Ispizua, M. V. Mateos, M. Juan, B. Paiva, M. Pascal, C. Fernández de Larrea

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM)

    P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) by M. Dimopoulos, S. Opat, S. D’Sa, W. Jurczak, H.-P. Lee, G. Cull, R. G. Owen, P. Marlton, B. E. Wahlin, R. Garcia-Sanz, H. McCarthy, S. Mulligan, A. Tedeschi, J. J. Castillo, J. Czyz, C. Fernandez De Larrea Rodriguez, D. Belada, E. Libby, J. Matous, M. Motta, T. Siddiqi, M. Tani, M. Trneny, M. Minnema, C. Buske, V. Leblond, S. P. Treon, J. Trotman, W. Y. Chan, J. Schneider, H. Allewelt, A. Cohen, J. Huang, C. S. Tam

    Published 2022-06-01
    Get full text
    Article
  4. 4
    S103: EFFICACY AND SAFETY OF ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR-T CELL THERAPY WITH FRACTIONATED INITIAL THERAPY AND BOOSTER DOSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

    S103: EFFICACY AND SAFETY OF ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR-T CELL THERAPY WITH FRACTIONATED INITIAL THERAPY AND BOOSTER DOSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE... by C. Fernandez De Larrea, V. González-Calle, A. Oliver-Caldés, V. Cabañas, P. Rodríguez-Otero, M. Español-Rego, J. L. Reguera, L. López-Corral, B. Martin-Antonio, B. Paiva, S. Inogés, L. Rosiñol, A. López-Díaz de Cerio, N. Tovar, M. López-Parra, L. G. Rodríguez-Lobato, A. Sánchez-Salinas, S. Varea, V. Ortiz-Maldonado, J. A. Pérez Simón, F. Prósper, M. Juan, J. M. Moraleda, M. V. Mateos, M. Pascal, A. Urbano-Ispizua

    Published 2022-06-01
    Get full text
    Article

Search Tools: